GF Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
GF Fund Management's BMRN Position: Q3 2026 in Review
GF Fund Management increased its BioMarin Pharmaceuticals (BMRN) stake by 8.9% in Q3 2026, buying an estimated $22.9K and bringing the position to 4,434 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #253.
GF Fund Management first reported a position in BMRN in Q4 2024 and has held it in 8 quarters since. The position peaked at $345K in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- GF Fund Management held 4,434 shares of BioMarin Pharmaceuticals worth $266K as of Q3 2026.
- GF Fund Management bought 363 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $22.9K.
- BioMarin Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #253 holding.
- GF Fund Management first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's BioMarin Pharmaceuticals position peaked at $345K in Q1 2025.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.